C

    COEP (COEP)

    Official site

    BIOTECHNOLOGY

    $16.40
    +0.19 (+1.17%)

    Last updated: Apr 24, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    33%(3/9)
    Avg Surprise
    -1023.59%
    PeriodReportedEst.SurpriseB/MYoY
    Sep 25
    		$-0.58$0.00N/AMiss+46.3%
    Jun 25
    		$-0.95$0.00N/AMiss+44.1%
    Mar 25
    		$-0.95$-0.04-2275.00%Miss-1025.6%
    Dec 24
    		$-1.42$0.09-1681.33%Miss-7.0%
    Sep 24
    		$-1.08$-1.00-8.00%Miss+76.5%
    Jun 24
    		$-1.70$-1.80+5.56%Beat+28.3%
    Mar 24
    		$-0.08$0.00N/ABeat+98.7%
    Dec 23
    		$-1.33N/A+58.44%Beat+48.6%
    Sep 23
    		$-4.60$-0.20-2200.00%Miss-7618.1%
    Jun 23
    		$-2.37$-4.00+40.75%Beat-7800.0%
    Mar 23
    		$-6.45$-5.60-15.18%Miss-4861.5%
    Dec 22
    		$-2.59$-0.08-3137.50%Miss-3137.5%
    Sep 22
    		$-0.06N/AN/ABeat-113.2%
    Jun 22
    		$-0.03N/AN/ABeat-102.0%
    Mar 22
    		$-0.13N/AN/ABeat-85.7%
    Dec 21
    		$-0.08N/AN/ABeat-700.0%
    Sep 21
    		$0.45N/AN/ABeat+4600.0%
    Jun 21
    		$1.50N/AN/ABeat+1761.1%
    Mar 21
    		$-0.07N/AN/ABeat-85.2%
    Dec 20
    		$-0.01$0.00N/AMiss-
    Sep 20
    		$-0.01N/AN/ABeat-
    Jun 20
    		$-0.09N/AN/ABeat-
    Mar 20
    		$-0.04$0.00N/AMiss-
    Sep 19
    		$0.00$0.00N/ABeat-

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit MarginN/AOperating MarginN/A
    ROEN/AROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current RatioN/AQuick RatioN/A
    Trading Statistics
    BetaN/AAvg VolumeN/A
    52-Week HighN/A52-Week LowN/A

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$14.41
    SMA 20$12.88
    SMA 50$12.26
    SMA 200$13.58
    EMA 10$14.65
    EMA 20$13.59
    EMA 50$12.89
    EMA 200$12.89

    MACD

    Line: 1.10Signal: 0.63Hist: 0.47

    ADX

    ADX: 26.0+DI: 40.6-DI: 10.5

    Aroon & PSAR

    Aroon Up100.0
    Aroon Down12.0
    PSAR$12.89

    Bollinger Bands

    Upper Band$16.78
    Lower Band$8.98
    %B Position6059%(Upper)
    Band Width0.95

    RSI (14-Day)

    Overbought
    72.1

    Momentum Oscillators

    Stoch %K89.6
    Stoch %D87.3
    Williams %R-12.3
    ROC (10d)37.2%
    Momentum4.45
    CCI (20d)154.6
    MFI (14d)79.5

    Volatility Measures

    ATR (14d)$1.09(6.6%)
    StdDev (20d)1.95
    Hist Vol89.9%(High)

    Volume Flow

    VWAP$16.51
    OBV399.1K
    AD Line22.0K
    CMF (20d)0.155

    Volume Metrics

    Avg Vol (20d)57.8K
    Vol Ratio1.9x(High)
    VWMA (20d)$13.62

    Pivot Points

    R3$18.02
    R2$17.18
    R1$16.69
    Pivot Point$15.85
    S1$15.36
    S2$14.52
    S3$14.03

    Advanced Oscillators

    TSI29.51
    Ultimate Osc64.1
    KST210.23

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$3.17M$113,771$862,049$237,441$0$62,874$1.86M$0$0$0$1.50M$0
    Cost of Revenue$6.70M$45,156$45,157$45,155$0$45,156$259,982$0$0$0$250,309$0
    Gross Profit$-1,765,947$68,615$816,892$192,286$0$17,718$-259,982$0$0$0$-250,309$0
    Operating Expenses$23.98M$3.98M$2.81M$2.67M$0$4.07M$2.16M$2.14M$2.83M$2.92M$3.37M$7.90M
    R&D$0$235,529$312,903$587,279$0$86,659$343,878$811,784$398,817$777,069$1.01M$5.07M
    SG&A$4.21M$1.66M$1.58M$1.26M$0$2.59M$834,853$604,377$1.10M$1.35M$1.43M$2.07M
    Operating Income$-13,794,600$-3,914,644$-1,988,272$-2,477,028$0$-4,056,984$-2,162,214$-2,141,789$-2,828,102$-2,922,383$-3,365,970$-7,901,220
    Interest Income$0$-22,688$0$0$0$0$0$0$0$0$0$0
    Interest Expense$226$5,257$440,490$62,610$0$71,491$144,818$50,926$66,056$200,505$13,832$19,800
    Income Before Tax$-13,794,745$-4,020,896$-1,622,902$-2,898,763$0$-3,420,941$-3,011,765$-1,828,914$-3,035,345$-3,001,388$-3,755,590$-6,350,494
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-27,517,240$-7,937,514$-1,622,902$-2,898,763$0$-6,777,479$-3,011,765$-1,828,914$-3,035,345$-3,001,388$-3,755,590$-6,350,494
    EBITDA$-12,828,999$-3,682,443$-829,399$-2,472,394$-405,176$-2,944,274$-2,775,518$-1,499,759$-2,728,208$-2,391,542$-3,487,132$-6,050,150
    EBIT$-13,794,664$-3,992,951$-1,135,407$-2,836,153$0$-3,349,450$-3,101,689$-1,777,988$-2,969,289$-2,800,883$-3,741,756$-6,330,696
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about COEP

    News

    (COEP) Price Dynamics and Execution-Aware Positioning

    This article from Stock Traders Daily discusses Coeptis Therapeutics Holdings Inc. (COEP), providing an AI-generated analysis of its price dynamics. It highlights key findings and offers various institutional trading strategies including position trading, momentum breakout, and risk hedging. The piece also details multi-timeframe signal analysis and encourages users to sign in for full access to real-time signals and personalized alerts.

    Stock Traders Daily•8/6/26•
    Neutral

    Coeptis Therapeutics Holdings Inc (COEPW) Financial Health: Profitability & Balance Sheet Analysis

    This article from TradingKey provides a financial health analysis of Coeptis Therapeutics Holdings Inc (COEPW), focusing on profitability and balance sheet aspects. It notes that relevant financial data regarding cash, assets, liabilities, free cash flow, revenue, operating profit, and operational efficiency has not yet been disclosed by the company, making a detailed analysis impossible at this time. The piece also highlights the stock's current trading status and mentions various financial dimensions without providing specific figures.

    TradingKey•6/19/26•
    Neutral

    Coeptis Therapeutics Holdings Inc (COEPW) Technical Analysis: Support, Resistance, Indicators & Moving Averages

    This article provides a technical analysis of Coeptis Therapeutics Holdings Inc (COEPW), detailing its support, resistance levels, and various technical indicators. It presents a summary of buy, neutral, and sell signals based on popular indicators like MACD, RSI, and moving averages. The analysis suggests a lean towards sell or neutral signals across most indicators and moving averages, while also explaining the nature of technical ratings and moving averages.

    TradingKey•6/19/26•
    Neutral

    Coeptis Therapeutics Holdings Inc (COEPW) Earnings Forecast: Future EPS & Revenue Growth Estimates

    This article from TradingKey concerns Coeptis Therapeutics Holdings Inc (COEPW) and its earnings forecast. It notes that relevant EPS, Revenue, Net Profit, and EBIT data have not yet been disclosed by the company, preventing a detailed financial forecast. The page provides a framework for analyzing the company's financial health, valuation, and risk assessment once the data becomes available.

    TradingKey•6/19/26•
    Neutral

    Coeptis Therapeutics Holdings Inc (COEPW) Institutional Confidence

    This article provides details on the institutional confidence score for Coeptis Therapeutics Holdings Inc (COEPW). It lists various institutional investors and their shareholdings, showing changes in their positions. The overall institutional confidence score is currently 0, with some institutions increasing their holdings and others decreasing or fully exiting.

    TradingKey•6/19/26•
    Neutral

    Frequently Asked Questions About COEP

    Does COEP pay dividends?
    COEP (COEP) does not currently pay a regular dividend.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In